Diabetes-Induced Extracellular Matrix Protein Expression Is Mediated by Transcription Coactivator p300

  1. Harkiran Kaur1,
  2. Shali Chen1,
  3. Xiping Xin1,
  4. Jane Chiu1,
  5. Zia A. Khan12 and
  6. Subrata Chakrabarti13
  1. 1Department of Pathology, University of Western Ontario, London, Ontario, Canada
  2. 2Vascular Biology Program and Department of Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts
  3. 3Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada
  1. Address correspondence and reprint requests to Dr. Subrata Chakrabarti, Department of Pathology, 4011 Dental Sciences Building, University of Western Ontario, London, Ontario, Canada. E-mail: subrata.chakrabarti{at}schulich.uwo.ca


Increased fibronectin expression is a key feature of diabetic angiopathy. We have previously shown that nuclear factor-κB (NF-κB) mediates fibronectin expression in endothelial cells and in organs affected by diabetes complications. p300, a transcription coactivator, may regulate NF-κB activity via poly(ADP-ribose) polymerase (PARP) activation. Hence, we examined the role of p300 in fibronectin expression in diabetes. High glucose induced fibronectin expression in the endothelial cells, which was associated with increased p300, PARP activity, and NF-κB activation. This p300 alteration is mediated by mitogen-activated protein kinase and protein kinase C and B. We then used p300 small interfering RNA (siRNA) and showed decreased fibronectin and PARP expression, as well as NF-κB activation, in the endothelial cells. Examination of the heart tissues of streptozotocin-induced diabetic mice revealed increased fibronectin and p300 mRNA. Intravenous injection of p300 siRNA resulted in decreased p300 levels and normalized fibronectin expression in the heart. We further investigated retinal tissues from streptozotocin-induced diabetic rats treated with intravitreal p300 siRNA injection. Similar to the heart, p300 siRNA inhibited fibronectin expression in the retina of the diabetic animals. These results indicate that transcriptional coactivator p300 may regulate fibronectin expression via PARP and NF-κB activation in diabetes.


  • H.K. and S.C. contributed equally to this work.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted July 24, 2006.
    • Received April 17, 2006.
| Table of Contents